Mackenzie Financial Corp Cara Therapeutics, Inc. Transaction History
Mackenzie Financial Corp
- $65 Billion
- Q1 2024
A detailed history of Mackenzie Financial Corp transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 21,176 shares of CARA stock, worth $6,988. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,176
Previous 53,678
60.55%
Holding current value
$6,988
Previous $39,000
51.28%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CARA
# of Institutions
102Shares Held
21.5MCall Options Held
50KPut Options Held
0-
Black Rock Inc. New York, NY3.42MShares$1.13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.48MShares$818,8150.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.82MShares$598,9690.03% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$561,6960.15% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$513,5620.01% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $17.7M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...